Showing results (161-170 of 283) with videos related to
Sort By:
Pageof 29
Plos One|January 23, 2016
Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6Angela Corona, Rita Meleddu, Francesca Esposito, et al.Journal of Ethnopharmacology|June 26, 2025
Salvia officinalis L. leaf extracts: Chemical analysis and biological studiesJessica Ceramella, Daniel Chavarria, Domenico Iacopetta, et al.European Journal of Medicinal Chemistry|December 3, 2019
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndromeDonatella Bagetta, Annalisa Maruca, Antonio Lupia, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 19, 2021
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivativesRita Meleddu, Serenella Deplano, Elias Maccioni, et al.European Journal of Medicinal Chemistry|August 10, 2019
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profileAnnalisa Maruca, Raffaella Catalano, Donatella Bagetta, et al.European Journal of Medicinal Chemistry|April 29, 2019
Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agentsCatarina Oliveira, Donatella Bagetta, Fernando Cagide, et al.Antioxidants (Basel, Switzerland)|May 27, 2023
Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro StudiesGianmarco Gualtieri, Annalisa Maruca, Roberta Rocca, et al.European Journal of Medicinal Chemistry|November 12, 2017
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agentsSimone Carradori, Francesco Ortuso, Anél Petzer, et al.Journal of Amino Acids|March 28, 2013
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 InhibitorsErmelinda Vernieri, Isabel Gomez-Monterrey, Ciro Milite, et al.European Journal of Pharmacology|July 20, 2002
Modeling and biological evaluation of 3,3'-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitorRosaria Ottaná, Emanuela Mazzon, Laura Dugo, et al.Pageof 29